Insights from 2023 ESMO Annual Meeting
J

ESMO 2023 Insights: "mRNA-4157 (V940) Individualized Neoantigen Therapy + Pembro vs. Pembro in High-Risk Resected Melanoma"

By Insights from 2023 ESMO Annual Meeting FEATURING Jeffrey Weber
By Insights from 2023 ESMO Annual Meeting FEATURING Jeffrey Weber
175 views
November 1, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
23:09
Total Health

Key Updates in Skin Melanoma

Feat. R. Seedor
17:39
Melanoma Bridge 2023

Major Emerging Paradigm Shifts That Will Change Melanoma Management …

Feat. A. Eggermont
19:52
OncoAlert

Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…

Feat. A. Betof Warner
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
18:21
Vanderbilt University Medical Center (VUMC)

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Feat. D. Johnson
14:00
Melanoma Bridge 2023

Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…

Feat. J. Luke
25:10
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Immunotherapy Combinations in Melanoma in 2024

Feat. J. Moyers
30:29
NYU Langone

Updates in Treatment with Immunotherapy for Melanoma and Related Mal…

Feat. J. Weber
20:55
2023 West Oncology Conference

2023 West Oncology Conference: Melanoma Updates

Feat. M. Mooradian
11:56
Melanoma Bridge 2023

Adjuvant Therapy in Stage II Melanoma: Tools to Balance the Choice

Feat. P. Ascierto
04:40
Winship Melanoma and Cutaneous Oncology Symposium

74 y/o Male With Melanoma Who Progressed on Adjuvant Therapy: Case D…

Feat. M. Yushak, R. Sinha, S. Patel, J. Mehnert
19:12
Melanoma Bridge 2023

Adjuvant IO in Stage II Melanoma

Feat. A. Arance
11:18
Melanoma Bridge 2023

Biomarkers Directing Melanoma Immunotherapy: Useful or Not Useful?

Feat. A. Eggermont
13:20
Penn Medicine Abramson Cancer Center

Penn Medicine Updates in Oncology 2023: Melanoma

Feat. J. Cohen
12:36
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "SWOG S1801 - Pathologic Response & Exp…

Feat. S. Patel
27:29
Total Health

2023 ASCO® Direct Philadelphia: Melanoma Updates

Feat. M. Orloff
21:38
Penn Medicine Abramson Cancer Center

Updates in Systemic Therapy for Melanoma

Feat. T. Mitchell
11:21
Massachusetts General Hospital Cancer Center

Uveal Melanoma for Community Oncologists

Feat. K. Montazeri
12:18
Omid Hamid

Adjuvant Therapy in Melanoma Q&A Session: Personalized mRNA Canc…

Feat. R. Sullivan